Jiang C, Du Y, Liu X, Wang J, et al. Safety, tolerability, pharmacokinetics and efficacy of HB0017, a humanized monoclonal antibody targeting IL-17A, in healthy subjects and patients with moderate to severe plaque psoriasis (PsO). Br J Dermatol 2023 Sep 5:ljad315. doi: 10.1093.
PMID: 37669307